메뉴 건너뛰기




Volumn 8, Issue 4, 2013, Pages

Erratum: Expression of Concern: Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies (PLoS ONE (2013) 8:4 (e60817) DOI: 10.1371/journal.pone.0060817);Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYESTRADIOL; GELATINASE A; GELATINASE B; GLYCOPROTEIN GP 130; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ALPHA; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN MCL 1; STAT3 PROTEIN;

EID: 84875967041     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0298444     Document Type: Erratum
Times cited : (43)

References (63)
  • 2
    • 84859219044 scopus 로고    scopus 로고
    • Inflammation and ovarian cancer
    • Maccio A, Madeddu C, (2012) Inflammation and ovarian cancer. Cytokine 58: 133-147.
    • (2012) Cytokine , vol.58 , pp. 133-147
    • Maccio, A.1    Madeddu, C.2
  • 4
    • 84865422083 scopus 로고    scopus 로고
    • Interleukin-6 signaling pathway in targeted therapy for cancer
    • Guo Y, Xu F, Lu T, Duan Z, Zhang Z (2012) Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev.
    • (2012) Cancer Treat Rev
    • Guo, Y.1    Xu, F.2    Lu, T.3    Duan, Z.4    Zhang, Z.5
  • 5
    • 84875995133 scopus 로고    scopus 로고
    • Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer
    • Gastl G, Plante M, (2001) Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Methods Mol Med 39: 121-123.
    • (2001) Methods Mol Med , vol.39 , pp. 121-123
    • Gastl, G.1    Plante, M.2
  • 6
    • 84867499521 scopus 로고    scopus 로고
    • Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
    • Dijkgraaf EM, Welters MJ, Nortier JW, van der Burg SH, Kroep JR, (2012) Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer. Curr Pharm Des 18: 3816-3827.
    • (2012) Curr Pharm Des , vol.18 , pp. 3816-3827
    • Dijkgraaf, E.M.1    Welters, M.J.2    Nortier, J.W.3    van der Burg, S.H.4    Kroep, J.R.5
  • 7
    • 84862304990 scopus 로고    scopus 로고
    • Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells
    • Wang Y, Li L, Guo X, Jin X, Sun W, et al. (2012) Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells. Cytokine 59: 228-236.
    • (2012) Cytokine , vol.59 , pp. 228-236
    • Wang, Y.1    Li, L.2    Guo, X.3    Jin, X.4    Sun, W.5
  • 8
    • 77953611991 scopus 로고    scopus 로고
    • Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
    • Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, et al. (2010) Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cancer Lett 295: 110-123.
    • (2010) Cancer Lett , vol.295 , pp. 110-123
    • Wang, Y.1    Niu, X.L.2    Qu, Y.3    Wu, J.4    Zhu, Y.Q.5
  • 9
    • 78751549236 scopus 로고    scopus 로고
    • IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer
    • Lo CW, Chen MW, Hsiao M, Wang S, Chen CA, et al. (2011) IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer. Cancer Res 71: 424-434.
    • (2011) Cancer Res , vol.71 , pp. 424-434
    • Lo, C.W.1    Chen, M.W.2    Hsiao, M.3    Wang, S.4    Chen, C.A.5
  • 10
    • 77449086394 scopus 로고    scopus 로고
    • Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients
    • Maccio A, Madeddu C, Massa D, Astara G, Farci D, et al. (2008) Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients. J Cell Mol Med.
    • (2008) J Cell Mol Med
    • Maccio, A.1    Madeddu, C.2    Massa, D.3    Astara, G.4    Farci, D.5
  • 11
    • 0035164602 scopus 로고    scopus 로고
    • The soluble interleukin 6 receptor: mechanisms of production and implications in disease
    • Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM, (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 15: 43-58.
    • (2001) FASEB J , vol.15 , pp. 43-58
    • Jones, S.A.1    Horiuchi, S.2    Topley, N.3    Yamamoto, N.4    Fuller, G.M.5
  • 12
    • 85185194467 scopus 로고    scopus 로고
    • Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer
    • Ataie-Kachoie P, Pourgholami MH, Morris DL (2012) Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer. Cytokine Growth Factor Rev.
    • (2012) Cytokine Growth Factor Rev
    • Ataie-Kachoie, P.1    Pourgholami, M.H.2    Morris, D.L.3
  • 13
    • 77956824007 scopus 로고    scopus 로고
    • Minocycline in the treatment of acne: latest findings
    • Maffeis L, Veraldi S, (2010) Minocycline in the treatment of acne: latest findings. G Ital Dermatol Venereol 145: 425-429.
    • (2010) G Ital Dermatol Venereol , vol.145 , pp. 425-429
    • Maffeis, L.1    Veraldi, S.2
  • 14
    • 0034820120 scopus 로고    scopus 로고
    • Minocycline as a therapeutic option in bullous pemphigoid
    • Loo WJ, Kirtschig G, Wojnarowska F, (2001) Minocycline as a therapeutic option in bullous pemphigoid. Clin Exp Dermatol 26: 376-379.
    • (2001) Clin Exp Dermatol , vol.26 , pp. 376-379
    • Loo, W.J.1    Kirtschig, G.2    Wojnarowska, F.3
  • 15
    • 80054114703 scopus 로고    scopus 로고
    • Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects
    • Smith CJ, Sayles H, Mikuls TR, Michaud K, (2011) Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects. Arthritis Res Ther 13: R168.
    • (2011) Arthritis Res Ther , vol.13
    • Smith, C.J.1    Sayles, H.2    Mikuls, T.R.3    Michaud, K.4
  • 17
    • 79958205912 scopus 로고    scopus 로고
    • Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study
    • Leite LM, Carvalho AG, Ferreira PL, Pessoa IX, Goncalves DO, et al. (2011) Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study. Inflammopharmacology 19: 99-110.
    • (2011) Inflammopharmacology , vol.19 , pp. 99-110
    • Leite, L.M.1    Carvalho, A.G.2    Ferreira, P.L.3    Pessoa, I.X.4    Goncalves, D.O.5
  • 18
    • 76649110556 scopus 로고    scopus 로고
    • Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model
    • Cai ZY, Yan Y, Chen R, (2010) Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model. Neurosci Bull 26: 28-36.
    • (2010) Neurosci Bull , vol.26 , pp. 28-36
    • Cai, Z.Y.1    Yan, Y.2    Chen, R.3
  • 19
    • 79957933723 scopus 로고    scopus 로고
    • Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice
    • Park CH, Shin TK, Lee HY, Kim SJ, Lee WS, (2011) Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice. Korean J Physiol Pharmacol 15: 115-122.
    • (2011) Korean J Physiol Pharmacol , vol.15 , pp. 115-122
    • Park, C.H.1    Shin, T.K.2    Lee, H.Y.3    Kim, S.J.4    Lee, W.S.5
  • 20
    • 79953742214 scopus 로고    scopus 로고
    • Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS
    • Campbell JH, Burdo TH, Autissier P, Bombardier JP, Westmoreland SV, et al. (2011) Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS. PLoS One 6: e18688.
    • (2011) PLoS One , vol.6
    • Campbell, J.H.1    Burdo, T.H.2    Autissier, P.3    Bombardier, J.P.4    Westmoreland, S.V.5
  • 21
    • 79960416799 scopus 로고    scopus 로고
    • Interleukin-6, Produced by Resident Cells of the Central Nervous System and Infiltrating Cells, Contributes to the Development of Seizures Following Viral Infection
    • Libbey JE, Kennett NJ, Wilcox KS, White HS, Fujinami RS (2011) Interleukin-6, Produced by Resident Cells of the Central Nervous System and Infiltrating Cells, Contributes to the Development of Seizures Following Viral Infection. J Virol.
    • (2011) J Virol
    • Libbey, J.E.1    Kennett, N.J.2    Wilcox, K.S.3    White, H.S.4    Fujinami, R.S.5
  • 22
    • 33646534607 scopus 로고    scopus 로고
    • Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain
    • Zanjani TM, Sabetkasaei M, Mosaffa N, Manaheji H, Labibi F, et al. (2006) Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain. Eur J Pharmacol 538: 66-72.
    • (2006) Eur J Pharmacol , vol.538 , pp. 66-72
    • Zanjani, T.M.1    Sabetkasaei, M.2    Mosaffa, N.3    Manaheji, H.4    Labibi, F.5
  • 23
    • 0021879340 scopus 로고
    • The antitumour effect of doxycycline on a T-cell leukaemia in the rat
    • van den Bogert C, Dontje BH, Kroon AM, (1985) The antitumour effect of doxycycline on a T-cell leukaemia in the rat. Leuk Res 9: 617-623.
    • (1985) Leuk Res , vol.9 , pp. 617-623
    • van den Bogert, C.1    Dontje, B.H.2    Kroon, A.M.3
  • 24
    • 77953226760 scopus 로고    scopus 로고
    • Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells
    • Shieh JM, Huang TF, Hung CF, Chou KH, Tsai YJ, et al. (2010) Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells. Br J Pharmacol 160: 1171-1184.
    • (2010) Br J Pharmacol , vol.160 , pp. 1171-1184
    • Shieh, J.M.1    Huang, T.F.2    Hung, C.F.3    Chou, K.H.4    Tsai, Y.J.5
  • 25
    • 0022640113 scopus 로고
    • Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis
    • van den Bogert C, Dontje BH, Holtrop M, Melis TE, Romijn JC, et al. (1986) Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis. Cancer Res 46: 3283-3289.
    • (1986) Cancer Res , vol.46 , pp. 3283-3289
    • van den Bogert, C.1    Dontje, B.H.2    Holtrop, M.3    Melis, T.E.4    Romijn, J.C.5
  • 26
    • 0035109570 scopus 로고    scopus 로고
    • Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells
    • Meng Q, Xu J, Goldberg ID, Rosen EM, Greenwald RA, et al. (2000) Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells. Clin Exp Metastasis 18: 139-146.
    • (2000) Clin Exp Metastasis , vol.18 , pp. 139-146
    • Meng, Q.1    Xu, J.2    Goldberg, I.D.3    Rosen, E.M.4    Greenwald, R.A.5
  • 28
    • 85185201103 scopus 로고    scopus 로고
    • Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways
    • Pourgholami MH, Ataie-Kachoie P, Badar S, Morris DL (2012) Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways. Gynecol Oncol.
    • (2012) Gynecol Oncol
    • Pourgholami, M.H.1    Ataie-Kachoie, P.2    Badar, S.3    Morris, D.L.4
  • 31
    • 2442715084 scopus 로고    scopus 로고
    • Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis
    • Gordon PH, Moore DH, Gelinas DF, Qualls C, Meister ME, et al. (2004) Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology 62: 1845-1847.
    • (2004) Neurology , vol.62 , pp. 1845-1847
    • Gordon, P.H.1    Moore, D.H.2    Gelinas, D.F.3    Qualls, C.4    Meister, M.E.5
  • 32
    • 80355123687 scopus 로고    scopus 로고
    • Gingival fibroblasts display reduced adhesion and spreading on extracellular matrix: a possible basis for scarless tissue repair?
    • Guo F, Carter DE, Mukhopadhyay A, Leask A, (2011) Gingival fibroblasts display reduced adhesion and spreading on extracellular matrix: a possible basis for scarless tissue repair? PLoS One 6: e27097.
    • (2011) PLoS One , vol.6
    • Guo, F.1    Carter, D.E.2    Mukhopadhyay, A.3    Leask, A.4
  • 33
    • 54449088686 scopus 로고    scopus 로고
    • Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1
    • Cahill CM, Rogers JT, (2008) Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1. J Biol Chem 283: 25900-25912.
    • (2008) J Biol Chem , vol.283 , pp. 25900-25912
    • Cahill, C.M.1    Rogers, J.T.2
  • 34
    • 84873169131 scopus 로고    scopus 로고
    • Ovarian epithelial-stromal interactions: role of interleukins 1 and 6
    • Woolery KT, Kruk PA, (2011) Ovarian epithelial-stromal interactions: role of interleukins 1 and 6. Obstet Gynecol Int 2011: 358493.
    • (2011) Obstet Gynecol Int , vol.2011 , pp. 358493
    • Woolery, K.T.1    Kruk, P.A.2
  • 36
    • 23744501325 scopus 로고    scopus 로고
    • Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells
    • Seeger H, Wallwiener D, Kraemer E, Mueck AO, (2005) Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells. Eur J Gynaecol Oncol 26: 383-385.
    • (2005) Eur J Gynaecol Oncol , vol.26 , pp. 383-385
    • Seeger, H.1    Wallwiener, D.2    Kraemer, E.3    Mueck, A.O.4
  • 37
    • 1642283086 scopus 로고    scopus 로고
    • 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells
    • Gao N, Nester RA, Sarkar MA, (2004) 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Toxicol Appl Pharmacol 196: 124-135.
    • (2004) Toxicol Appl Pharmacol , vol.196 , pp. 124-135
    • Gao, N.1    Nester, R.A.2    Sarkar, M.A.3
  • 40
    • 78649741783 scopus 로고    scopus 로고
    • gp130 at the nexus of inflammation, autoimmunity, and cancer
    • Silver JS, Hunter CA, (2010) gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol 88: 1145-1156.
    • (2010) J Leukoc Biol , vol.88 , pp. 1145-1156
    • Silver, J.S.1    Hunter, C.A.2
  • 41
    • 78650356983 scopus 로고    scopus 로고
    • Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer
    • Guo Y, Nemeth J, O'Brien C, Susa M, Liu X, et al. (2010) Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer. Clin Cancer Res 16: 5759-5769.
    • (2010) Clin Cancer Res , vol.16 , pp. 5759-5769
    • Guo, Y.1    Nemeth, J.2    O'Brien, C.3    Susa, M.4    Liu, X.5
  • 42
    • 77953091816 scopus 로고    scopus 로고
    • Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer
    • Dorff TB, Goldman B, Pinski JK, Mack PC, Lara PN Jr, et al. (2010) Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer. Clin Cancer Res 16: 3028-3034.
    • (2010) Clin Cancer Res , vol.16 , pp. 3028-3034
    • Dorff, T.B.1    Goldman, B.2    Pinski, J.K.3    Mack, P.C.4    Lara Jr., P.N.5
  • 43
    • 33751575658 scopus 로고    scopus 로고
    • The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis
    • Rosen DG, Mercado-Uribe I, Yang G, Bast RC Jr, Amin HM, et al. (2006) The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer 107: 2730-2740.
    • (2006) Cancer , vol.107 , pp. 2730-2740
    • Rosen, D.G.1    Mercado-Uribe, I.2    Yang, G.3    Bast Jr., R.C.4    Amin, H.M.5
  • 44
    • 70350525582 scopus 로고    scopus 로고
    • STAT3 regulation of glioblastoma pathogenesis
    • de la Iglesia N, Puram SV, Bonni A, (2009) STAT3 regulation of glioblastoma pathogenesis. Curr Mol Med 9: 580-590.
    • (2009) Curr Mol Med , vol.9 , pp. 580-590
    • de la Iglesia, N.1    Puram, S.V.2    Bonni, A.3
  • 45
    • 77249098774 scopus 로고    scopus 로고
    • Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice
    • Musteanu M, Blaas L, Mair M, Schlederer M, Bilban M, et al. (2010) Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice. Gastroenterology 138: 1003-1011 e1001-1005.
    • (2010) Gastroenterology , vol.138 , pp. 1001-1011
    • Musteanu, M.1    Blaas, L.2    Mair, M.3    Schlederer, M.4    Bilban, M.5
  • 47
    • 33947308781 scopus 로고    scopus 로고
    • Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10
    • Torres-Roca JF, DeSilvio M, Mora LB, Khor LY, Hammond E, et al. (2007) Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10. Urology 69: 505-509.
    • (2007) Urology , vol.69 , pp. 505-509
    • Torres-Roca, J.F.1    DeSilvio, M.2    Mora, L.B.3    Khor, L.Y.4    Hammond, E.5
  • 48
    • 84865023635 scopus 로고    scopus 로고
    • Cytokine gene expression signature in ovarian clear cell carcinoma
    • Yanaihara N, Anglesio MS, Ochiai K, Hirata Y, Saito M, et al. (2012) Cytokine gene expression signature in ovarian clear cell carcinoma. Int J Oncol 41: 1094-1100.
    • (2012) Int J Oncol , vol.41 , pp. 1094-1100
    • Yanaihara, N.1    Anglesio, M.S.2    Ochiai, K.3    Hirata, Y.4    Saito, M.5
  • 49
    • 84875991343 scopus 로고    scopus 로고
    • [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer]
    • Guo YQ, Lu P, Duan ZF, Zhang Z, (2010) [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer]. Zhonghua Fu Chan Ke Za Zhi 45: 854-859.
    • (2010) Zhonghua Fu Chan Ke Za Zhi , vol.45 , pp. 854-859
    • Guo, Y.Q.1    Lu, P.2    Duan, Z.F.3    Zhang, Z.4
  • 50
    • 0036554816 scopus 로고    scopus 로고
    • Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention
    • Buettner R, Mora LB, Jove R, (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8: 945-954.
    • (2002) Clin Cancer Res , vol.8 , pp. 945-954
    • Buettner, R.1    Mora, L.B.2    Jove, R.3
  • 51
    • 34548016800 scopus 로고    scopus 로고
    • STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes
    • Zhang X, Zhang J, Wei H, Tian Z, (2007) STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes. Oncol Rep 17: 1377-1382.
    • (2007) Oncol Rep , vol.17 , pp. 1377-1382
    • Zhang, X.1    Zhang, J.2    Wei, H.3    Tian, Z.4
  • 52
    • 31544458469 scopus 로고    scopus 로고
    • Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells
    • Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, et al. (2006) Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 12: 11-19.
    • (2006) Clin Cancer Res , vol.12 , pp. 11-19
    • Gritsko, T.1    Williams, A.2    Turkson, J.3    Kaneko, S.4    Bowman, T.5
  • 53
    • 58849152837 scopus 로고    scopus 로고
    • CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells
    • Duan Z, Ames RY, Ryan M, Hornicek FJ, Mankin H, et al. (2009) CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Cancer Chemother Pharmacol 63: 681-689.
    • (2009) Cancer Chemother Pharmacol , vol.63 , pp. 681-689
    • Duan, Z.1    Ames, R.Y.2    Ryan, M.3    Hornicek, F.J.4    Mankin, H.5
  • 54
    • 77951249948 scopus 로고    scopus 로고
    • [Relationship of IL-6 and IL-8 secretion in epithelial ovarian cancer cell lines with their sensitivity to tamoxifen as well as MAPK, Akt and estrogen receptor phosphorylation]
    • Wang Y, Guo XQ, Niu XL, Wu J, Zhu YQ, et al. (2010) [Relationship of IL-6 and IL-8 secretion in epithelial ovarian cancer cell lines with their sensitivity to tamoxifen as well as MAPK, Akt and estrogen receptor phosphorylation]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26: 21-24.
    • (2010) Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi , vol.26 , pp. 21-24
    • Wang, Y.1    Guo, X.Q.2    Niu, X.L.3    Wu, J.4    Zhu, Y.Q.5
  • 55
    • 25444488221 scopus 로고    scopus 로고
    • Modeling resistance to pathway-targeted therapy in ovarian cancer
    • Xing D, Orsulic S, (2005) Modeling resistance to pathway-targeted therapy in ovarian cancer. Cell Cycle 4: 1004-1006.
    • (2005) Cell Cycle , vol.4 , pp. 1004-1006
    • Xing, D.1    Orsulic, S.2
  • 56
    • 80052211582 scopus 로고    scopus 로고
    • Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding
    • Kleiman LB, Maiwald T, Conzelmann H, Lauffenburger DA, Sorger PK, (2011) Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding. Mol Cell 43: 723-737.
    • (2011) Mol Cell , vol.43 , pp. 723-737
    • Kleiman, L.B.1    Maiwald, T.2    Conzelmann, H.3    Lauffenburger, D.A.4    Sorger, P.K.5
  • 57
    • 37549039091 scopus 로고    scopus 로고
    • IL-1beta-stimulated activation of ERK1/2 and p38alpha MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-alpha in HeLa cells
    • Yang HT, Cohen P, Rousseau S, (2008) IL-1beta-stimulated activation of ERK1/2 and p38alpha MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-alpha in HeLa cells. Cell Signal 20: 375-380.
    • (2008) Cell Signal , vol.20 , pp. 375-380
    • Yang, H.T.1    Cohen, P.2    Rousseau, S.3
  • 58
    • 33746092509 scopus 로고    scopus 로고
    • Touched and moved by STAT3
    • Gao SP, Bromberg JF, (2006) Touched and moved by STAT3. Sci STKE 2006: pe30.
    • (2006) Sci STKE , vol.2006
    • Gao, S.P.1    Bromberg, J.F.2
  • 59
    • 4644372401 scopus 로고    scopus 로고
    • Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity
    • Bar JK, Grelewski P, Popiela A, Noga L, Rabczynski J, (2004) Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity. Gynecol Oncol 95: 23-31.
    • (2004) Gynecol Oncol , vol.95 , pp. 23-31
    • Bar, J.K.1    Grelewski, P.2    Popiela, A.3    Noga, L.4    Rabczynski, J.5
  • 60
    • 67651006538 scopus 로고    scopus 로고
    • Tocilizumab inhibits interleukin-6-mediated matrix metalloproteinase-2 and -9 secretions from human amnion cells in preterm premature rupture of membranes
    • Mano Y, Shibata K, Sumigama S, Hayakawa H, Ino K, et al. (2009) Tocilizumab inhibits interleukin-6-mediated matrix metalloproteinase-2 and-9 secretions from human amnion cells in preterm premature rupture of membranes. Gynecol Obstet Invest 68: 145-153.
    • (2009) Gynecol Obstet Invest , vol.68 , pp. 145-153
    • Mano, Y.1    Shibata, K.2    Sumigama, S.3    Hayakawa, H.4    Ino, K.5
  • 61
    • 79551663713 scopus 로고    scopus 로고
    • Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells
    • Hsu CP, Chen YL, Huang CC, Chou CC, Liu CL, et al. (2011) Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells. Eur J Clin Invest 41: 277-284.
    • (2011) Eur J Clin Invest , vol.41 , pp. 277-284
    • Hsu, C.P.1    Chen, Y.L.2    Huang, C.C.3    Chou, C.C.4    Liu, C.L.5
  • 62
    • 84864352003 scopus 로고    scopus 로고
    • Minocycline inhibits alkali burn-induced corneal neovascularization in mice
    • Xiao O, Xie ZL, Lin BW, Yin XF, Pi RB, et al. (2012) Minocycline inhibits alkali burn-induced corneal neovascularization in mice. PLoS One 7: e41858.
    • (2012) PLoS One , vol.7
    • Xiao, O.1    Xie, Z.L.2    Lin, B.W.3    Yin, X.F.4    Pi, R.B.5
  • 63
    • 77953473424 scopus 로고    scopus 로고
    • Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats
    • Bhatt LK, Addepalli V, (2010) Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats. Am J Transl Res 2: 181-189.
    • (2010) Am J Transl Res , vol.2 , pp. 181-189
    • Bhatt, L.K.1    Addepalli, V.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.